The Motley Fool

Should you buy big-yielding stocks Bovis Homes Group and this retirement homes builder?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Illustration of bull and bear
Image source: Getty Images.

At today’s share price of around 135p, retirement homes builder McCarthy & Stone’s  (LSE: MCS) forward dividend yield runs close to 4.7% for the trading year to August 2019, and anticipated forward earnings should cover the payment around 2.8 times. But the shares have been falling, down around 53% since January 2016, and today’s half-year results show us why that might be.

A tough trading period

Although the average selling price achieved by the firm was up 15% compared to a year ago, most other financial indicators moved in the wrong direction. Legal completions fell 12%, underlying operating profit sank by 40%, underlying basic earnings per share plunged 51%, and net debt shot up by an uncomfortable 150% to almost £76m.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

The firm puts the H1 outcome down to “ongoing subdued conditions in the secondary market” and fewer new “first occupations,” which it blames on “a pause in build start activity following the EU Referendum in June 2016.

Looking forward, uncertainty surrounding the government’s proposals on ground rents continues to hang over the company and it said: “We continue to work with the government to seek an exemption from these changes due to the unique viability model of retirement housing.” 

City analysts following McCarthy & Stone expect earnings to rise 10% for the year to August and 18% in 2019. The firm’s build programmes “remain on track” and the directors expect to return the balance sheet to a net cash position by the end of the current trading year. On the face of it, the immediate outlook is rosy, but the directors sounded a warning saying that fewer land exchanges and planning consents during the first half of the year means the growth trajectory for the business will be “more modest” over the next two years than they expected previously.

Chief executive Clive Fenton said the firm’s long-term prospects are positive because of a “growing need for retirement housing caused by our rapidly ageing population.”  Nevertheless, with the stock locked in the grip of a downtrend and earnings looking peaky, I’m cautious about the company’s big dividend yield and mindful of its cyclicality.

Awash with cash

There’s an even bigger dividend yield available from FTSE 250 constituent housebuilder Bovis Homes Group  (LSE: BVS). The big London-listed house builders all seem to be awash with cash and many have announced special dividends for 2018 onwards, including Bovis. With special dividends taken into account, Bovis has a forward yield running around 8.6% for 2018.

In 2017, revenue slipped 3% compared to the year before and earnings per share plunged 25%. However, City analysts’ forward earnings expectations are robust. They predict a 39% uplift this year and 14% during 2019.

Bovis is trading well, throwing off cash and the share price has been rising, but I’m too nervous to buy the stock. With both these two firms I ask myself, will the good times keep rolling? I know they are both highly cyclical firms and I know that cyclicals can look at their most attractive in terms of valuation and quality metrics when they are at their most dangerous. So, for me, the ‘right’ thing to do is to watch from the sidelines.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.